A new ECDC monitoring report shows that many EU/EEA countries are still not achieving the full benefits of early diagnosis for HIV, hepatitis B and hepatitis C.
In the latest monitoring report on HIV, hepatitis B (HBV) and hepatitis C (HCV) the ECDC reported that 27 countries have national HIV-testing policies, while 22 have recommendations on hepatitis B and C, only 17 have the ECDC’s preferred option of integrated testing for all three and sexually transmitted diseases…
To read the complete article, click here.
